HPHR Paper™ · No. 02
- Author
- Dr. Emmanuel Frantzis, DC, MSc, IFMCP, DACNB, DO(MP)
- Published
- Published September 2026
- Reading time
- 5 min read
- Level
- Intermediate
Scientific Foundation
The traditional explanation of pain emphasizes the transmission of nociceptive information from peripheral tissues to the brain. Although this ascending pathway remains fundamental to pain physiology, it represents only one component of a highly integrated regulatory system.
As discussed in the preceding paper, communication within the nervous system is fundamentally bidirectional. In addition to descending pathways that continuously influence spinal nociceptive processing, the central nervous system possesses intrinsic mechanisms capable of suppressing, amplifying, or modulating incoming sensory information before it contributes to conscious pain perception.¹² Appreciating these endogenous regulatory systems provides an important foundation for understanding why individuals exposed to similar nociceptive stimuli may experience pain very differently.
Landmark Concepts
The Physiology of Endogenous Pain Inhibition
Among the principal structures involved in endogenous pain modulation is the periaqueductal grey (PAG), a midbrain region that integrates information from cortical, subcortical, and limbic structures before influencing descending brainstem pathways. Through projections to the rostroventromedial medulla (RVM) and subsequently to the dorsal horn of the spinal cord, the PAG forms part of one of the nervous system’s major descending analgesic systems.¹²
These pathways are regulated through complex interactions involving endogenous opioids, γ-aminobutyric acid (GABA), serotonin, noradrenaline, glutamate, and numerous neuromodulatory systems. Their function extends beyond pain inhibition alone, contributing to behavioural adaptation, stress responses, defensive behaviour, and homeostatic regulation. Rather than operating as a simple “pain switch,” the PAG–RVM network continuously adjusts nociceptive processing according to physiological state, behavioural priorities, and environmental context.
Evidence for Descending Analgesia
Important mechanistic insight into this system was provided by Lau, Winters, and Vaughan (2020)², who examined the cellular physiology underlying endogenous opioid regulation of the PAG–RVM descending analgesic pathway.
Their work demonstrated that activation of μ-opioid receptors suppresses inhibitory GABAergic interneurons within the PAG, effectively disinhibiting projection neurons that activate descending analgesic pathways. This elegant mechanism illustrates how endogenous opioid systems facilitate pain inhibition not simply by reducing neuronal activity, but by selectively removing inhibitory influences within key components of the descending modulatory network.
These findings significantly advanced our understanding of the neurophysiology underlying endogenous pain inhibition and provided a mechanistic framework linking molecular neuroscience with systems-level regulation of nociceptive processing.
Clinical Evidence
Experimental neurophysiology becomes particularly meaningful when corresponding mechanisms can be demonstrated in clinical populations.
A landmark investigation by Julien and colleagues (2005)¹ compared endogenous pain inhibition in individuals with fibromyalgia, chronic low back pain, and healthy controls using conditioned pain modulation paradigms. Healthy participants and individuals with chronic low back pain demonstrated measurable endogenous inhibitory responses, whereas participants with fibromyalgia exhibited significantly impaired endogenous pain inhibition.
These observations suggest that alterations in intrinsic inhibitory systems may contribute to persistent pain in selected clinical populations. Importantly, such findings should not be interpreted as providing a universal explanation for chronic pain. Rather, they illustrate that differences in endogenous regulation represent one of several physiological mechanisms capable of influencing the pain experience.
Current Evidence
Recent investigations have continued to refine our understanding of the PAG–RVM–spinal cord network while revealing an increasingly complex organization of descending pain modulation. Contemporary neurophysiological and neuroimaging studies demonstrate that endogenous analgesia emerges through coordinated interactions involving the periaqueductal grey, rostroventromedial medulla, locus coeruleus, anterior cingulate cortex, anterior insula, amygdala, hypothalamus, and prefrontal cortex. These interconnected systems integrate nociceptive information with attention, emotional state, behavioural context, stress responses, and autonomic regulation, highlighting the distributed nature of endogenous pain control.³⁻⁵
Recent research has also emphasized that descending modulation reflects a dynamic balance between inhibitory and facilitatory influences rather than a purely analgesic system. This evolving perspective helps explain why pain regulation varies across individuals and clinical conditions while reinforcing one of the central themes of this paper: the nervous system is continuously regulating nociceptive information long before pain reaches conscious awareness.
Discussion
The recognition that the nervous system possesses intrinsic inhibitory mechanisms has fundamentally expanded contemporary approaches to pain physiology. Persistent pain can no longer be understood solely by examining the magnitude of nociceptive input arising from peripheral tissues. Instead, the experience of pain reflects continuous interaction between ascending sensory information and descending regulatory systems that modify nociceptive transmission according to physiological, cognitive, emotional, and behavioural influences.
This perspective does not diminish the importance of tissue pathology. Rather, it places tissue injury within the context of an adaptive nervous system whose regulatory capacity may differ considerably between individuals. Consequently, two people presenting with similar structural findings or nociceptive input may experience markedly different pain because the nervous systems responsible for processing that information are functioning differently.
Understanding endogenous pain inhibition therefore encourages clinicians to broaden their assessment beyond the tissues themselves and to consider how the nervous system regulates incoming sensory information. This represents an important step toward more comprehensive clinical reasoning and reinforces one of the central themes developed throughout this series: understanding pain begins with understanding the nervous system.
HPHR Clinical Perspective™
If two individuals receive similar nociceptive input, could differences in endogenous pain inhibition contribute to profoundly different pain experiences? More importantly, are we assessing the tissues alone, or are we also considering the nervous system responsible for regulating them?
Primary References
Julien, N., Goffaux, P., Arsenault, P., & Marchand, S. (2005). Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition. Pain, 114(1–2), 295–302. https://doi.org/10.1016/j.pain.2004.12.032
Lau, B. K., Winters, B. L., & Vaughan, C. W. (2020). Opioid presynaptic disinhibition of the midbrain periaqueductal grey descending analgesic pathway. British Journal of Pharmacology, 177(10), 2320–2332. https://doi.org/10.1111/bph.14982
Bushnell, M. C., Čeko, M., & Low, L. A. (2023). (Contemporary review of descending pain modulation and endogenous analgesia—final APA citation to be verified.)
Recent review of brainstem pain modulatory networks (2024). (Final APA citation to be verified during publication review.)
Recent systems neuroscience review of endogenous pain regulation (2025). (Final APA citation to be verified during publication review.)